Sort
25,944 grants matching “neurodegeneration”
TPA MEDIATED NEURODEGENERATION AND MICROGLIA ACTIVATION
$202,823State University New York Stony Brook · R01 · FY2001 · NS
GDF11: an age-variant hormonal regulator of tissue homeostasis and repair
$202,800Amy Jo Wagers · Harvard University · R56 · FY2016 · AG
Role of LRRK2 in immunity in a nonhuman primate model of SIV
$202,754Krystal Vail · Tulane University Of Louisiana · K01 · FY2024 · OD
Somatostain & Stress-Related Genes in HIV & Comorbid Major Depressive Disorder
$202,726Ian Paul Everall · University Of California, San Diego · R01 · FY2009 · MH
NG2 cells in Huntington's disease
$202,500Wenzhen Duan · Johns Hopkins University · R21 · FY2016 · NS
Non-apoptotic caspase activity in neurons
$202,500J. Marie Hardwick · Johns Hopkins University · R21 · FY2017 · NS
Environmental drivers of trinucleotide repeat instability and Huntington's disease onset
$202,500Brandon L Pearson · Columbia University Health Sciences · R21 · FY2022 · ES
Identification of novel system xc- inhibitors
$202,500Barbara Stauch Slusher · Johns Hopkins University · R21 · FY2012 · NS
Apathy in Alzheimer's Disease: Investigation of the Interaction between Proline and COMT for Treatment Targeting to Positively Impact Quality of Life
$202,500Catherine L Clelland · Columbia University Health Sciences · R21 · FY2018 · AG
Long-Term Safety, Efficacy, and Mechanism of PERK Inhibition Therapy for Prion Disease
$202,500Surachai Supattapone · Dartmouth College · R21 · FY2017 · NS
Investigating the Effect of APOE4 Expression on AD-relevant Tauopathy
$202,500Tal Nuriel · Columbia University Health Sciences · R21 · FY2020 · AG
Introducing Mitochondrial Stasis in Neurons
$202,500Hiromi Sesaki · Johns Hopkins University · R21 · FY2013 · NS
CHANGING TAU PROTEIN LEVELS AND TAU PROTEIN ISOFORMS IN MOUSE MODELS OF DEMENTIA
$202,495Timothy M. Miller · Washington University · P50 · FY2010 · AG
Basic and Clinical Studies of Noise-Induced and Age-Related Hearing Loss
$202,460Sharon Kujawa · Massachusetts Eye And Ear Infirmary · R01 · FY2009 · DC
Mechanisms of Polyglutamine Neurodegeneration
$202,450Henry L Paulson · University Of Michigan At Ann Arbor · R01 · FY2008 · NS
Early Events in Alzheimer Pathogenesis
$202,435Sue T Griffin · Univ Of Arkansas For Med Scis · P01 · FY2008 · AG
Project 6: Multimodal Longitudinal Network Bioimaging (MLNB)
$202,322William W Seeley · University Of California, San Francisco · P01 · FY2017 · AG
Optimization of compounds to improve mRNA splicing in familial dysautonomia
$202,278Susan A Slaugenhaupt · Massachusetts General Hospital · U01 · FY2012 · NS
CHANGING TAU PROTEIN LEVELS AND TAU PROTEIN ISOFORMS IN MOUSE MODELS OF DEMENTIA
$202,257Timothy M. Miller · Washington University · P50 · FY2014 · AG
Neuropathology Core
$202,194Mark Cohen · Cleveland Clinic Lerner Com-Cwru · P30 · FY2020 · AG
MURINE MODELS OF FRONTOTEMPORAL DEMENTIA
$202,130Robert V Farese · University Of California, San Francisco · P50 · FY2012 · AG
Mechanisms of Toxicity in C. elegans Models of Transthyretin Amyloidosis
$202,057Sandra E Encalada · Scripps Research Institute, The · R01 · FY2019 · AG
Neurogenesis and neurodegeneration in adolescent binge alcohol exposure
$202,005Kimberly Nixon · University Of Kentucky · R21 · FY2008 · AA
In vivo Molecular MR Imaging of Inflammation using NSAIDs as CEST agents
$202,000Xiaolei Song · Hugo W. Moser Res Inst Kennedy Krieger · R21 · FY2017 · EB
Neural, Inflammatory, and Genomic Mechanisms Underlying Risk for Depression in Adolescence
$201,960George Michael Slavich · University Of California Los Angeles · K08 · FY2018 · MH